Lenacapavir: A Beacon of Hope, or a Privileged Prescription?
The pharmaceutical industry has been criticized for prioritizing profit over people, and the rollout of lenacapavir – a revolutionary twice a year injection that can prevent HIV infection – is no exception.
While its remarkable effectiveness is undeniable, concerns are growing about the inequitable distribution of this lifesaving medication.